Bio-Rad Laboratories (BIO-B) Finished Goods (2009 - 2022)

Bio-Rad Laboratories (BIO-B) has 14 years of Finished Goods data on file, last reported at $309.9 million in Q2 2022.

• Quarterly Finished Goods fell 6.18% year-over-year to $309.9 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $309.9 million (down 6.18% YoY) and the FY2021 annual result came in at $312.6 million, down 8.97% from the prior year.
• Finished Goods climbed to $309.9 million in Q2 2022 per BIO-B's latest filing, from $306.0 million in the prior quarter.
• Across five years, Finished Goods topped out at $354.1 million in Q1 2018 and bottomed at $298.3 million in Q4 2019.
• The 5-year median for Finished Goods is $331.6 million (2018), against an average of $327.5 million.
• The widest annual swing landed in 2019, when Finished Goods slipped 9.81%; it then grew 15.12% in 2020.
• Tracing BIO-B's Finished Goods over 5 years: stood at $330.8 million in 2018, then decreased by 9.81% to $298.3 million in 2019, then increased by 15.12% to $343.4 million in 2020, then decreased by 8.97% to $312.6 million in 2021, then dropped by 0.88% to $309.9 million in 2022.
• Per Business Quant, the three latest BIO-B Finished Goods figures stand at $309.9 million (Q2 2022), $306.0 million (Q1 2022), and $312.6 million (Q4 2021).

Peer Comparison